AptaBio Therapeutics Inc. 293780.KQ Stock
5870 KRW
{{ price }}
-2.329451%
{{change_pct}}%
COUNTRY
South Korea
Exchange
KOSDAQ
Market Cap
130.89B KRW
LOW - HIGH [24H]
5710
-
6000 KRW
VOLUME [24H]
27.6K KRW
{{ volume }}
P/E Ratio
0
Earnings per share
0 KRW
AptaBio Therapeutics Inc. Price Chart
AptaBio Therapeutics Inc. 293780.KQ Financial and Trading Overview
| AptaBio Therapeutics Inc. stock price | 5870 KRW |
| Previous Close | 10300 KRW |
| Open | 10330 KRW |
| Bid | 10190 KRW x N/A |
| Ask | 10500 KRW x N/A |
| Day's Range | 10180 - 10500 KRW |
| 52 Week Range | 9670 - 27600 KRW |
| Volume | 136.6K KRW |
| Avg. Volume | 246.89K KRW |
| Market Cap | 110.78B KRW |
| Beta (5Y Monthly) | 2.211615 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 KRW |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
293780.KQ Valuation Measures
| Enterprise Value | 217.24B KRW |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 2580.8608 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 5061.372 |
| Enterprise Value/EBITDA | -23.316 |
Trading Information
AptaBio Therapeutics Inc. Stock Price History
| Beta (5Y Monthly) | 2.211615 |
| 52-Week Change | -35.22% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 27600 KRW |
| 52 Week Low | 9670 KRW |
| 50-Day Moving Average | 11005.6 KRW |
| 200-Day Moving Average | 12242 KRW |
293780.KQ Share Statistics
| Avg. Volume (3 month) | 246.89K KRW |
| Avg. Daily Volume (10-Days) | 217.35K KRW |
| Shares Outstanding | 10.88M |
| Float | 14.8M |
| Short Ratio | N/A |
| % Held by Insiders | 33.53% |
| % Held by Institutions | 0.54% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | N/A |
| Trailing Annual Dividend Yield | N/A |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor | 2:1 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2021 |
| Most Recent Quarter (mrq) | September 30, 2022 |
| Next Fiscal Year End | December 31, 2022 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -22808.92% |
| Gross Margin | 74.74% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -9.78% |
| Return on Equity (ttm) | -17.46% |
Income Statement
| Revenue (ttm) | 42.92M KRW |
| Revenue Per Share (ttm) | 1.93 KRW |
| Quarterly Revenue Growth (yoy) | -21.69% |
| Gross Profit (ttm) | 219.35M KRW |
| EBITDA | -9317351424 KRW |
| Net Income Avi to Common (ttm) | -10339249152 KRW |
| Diluted EPS (ttm) | N/A |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 16.84B KRW |
| Total Cash Per Share (mrq) | 755.61 KRW |
| Total Debt (mrq) | 298.93M KRW |
| Total Debt/Equity (mrq) | 0.55 KRW |
| Current Ratio (mrq) | 21.424 |
| Book Value Per Share (mrq) | N/A |
Cash Flow Statement
| Operating Cash Flow (ttm) | -6689345536 KRW |
| Levered Free Cash Flow (ttm) | -7153924096 KRW |
Profile of AptaBio Therapeutics Inc.
| Country | South Korea |
| State | N/A |
| City | Yongin-si |
| Address | Tower 504, 13 |
| ZIP | 16954 |
| Phone | 82 70 7152 0097 |
| Website | https://www.aptabio.com |
| Industry | |
| Sector(s) | |
| Full Time Employees | N/A |
AptaBio Therapeutics Inc. discovers and develops selective inhibitors of the NOX family of enzymes and aptamer-based anti-cancer drugs. The company offers Lipofector-Q, Lipofector-EXT, Lipofector-2000, Lipofector-EZ, and Lipofector-pMAX Reagent for transfecting DNA or RNA into eukaryotic cells. Its product candidates include PX-115 for treating diabetic nephropathy; APX-1004 to treat diabetic retinopathy; and APX-311 for use in treating non-alcoholic steatohepatitis (NASH). The company was founded in 2009 and is based in Yongin-Si, South Korea.
Q&A For AptaBio Therapeutics Inc. Stock
What is a current 293780.KQ stock price?
AptaBio Therapeutics Inc. 293780.KQ stock price today per share is 5870 KRW.
How to purchase AptaBio Therapeutics Inc. stock?
You can buy 293780.KQ shares on the KOSDAQ exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for AptaBio Therapeutics Inc.?
The stock symbol or ticker of AptaBio Therapeutics Inc. is 293780.KQ.
How many shares does AptaBio Therapeutics Inc. have in circulation?
The max supply of AptaBio Therapeutics Inc. shares is 22.3M.
What is AptaBio Therapeutics Inc. Price to Earnings Ratio (PE Ratio)?
AptaBio Therapeutics Inc. PE Ratio is now.
What was AptaBio Therapeutics Inc. earnings per share over the trailing 12 months (TTM)?
AptaBio Therapeutics Inc. EPS is 0 KRW over the trailing 12 months.
AptaBio Therapeutics Inc. 293780.KQ included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| Kosdaq Composite Index KQ11 | 848.53 KRW 0.64 USD |
-1.39
|
546.42K KRW 412 USD | 842.84 KRW 0.64 USD | 851.22 KRW 0.64 USD | — - | 546.42K KRW 412 USD |
| Kosdaq MID300 Index KQ300 | 720.6 KRW 0.54 USD |
-1.89
|
70.17K KRW 53 USD | 716.77 KRW 0.54 USD | 724.74 KRW 0.55 USD | — - | 70.17K KRW 53 USD |
| Kosdaq Other Services Index KQ16 | 3522.26 KRW 2.66 USD |
-2.5
|
15.31K KRW 12 USD | 3508.16 KRW 2.65 USD | 3576.45 KRW 2.7 USD | — - | 15.31K KRW 12 USD |
- {{ link.label }} {{link}}